Sun Pharma Advanced Research Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/05/2026 ,inter alia, to consider and approve the Audited ....
SPARC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
SPARC has informed exchanges that a Board Meeting is scheduled for May 18, 2026 to consider and approve the Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2026. The trading window for Directors, KMPs, and designated employees has been closed from April 1, 2026 and will remain so until 48 hours after the results are declared. This is a routine regulatory intimation under SEBI Listing Regulation 29 and does not contain any financial data or board decisions.
No immediate market impact as this is only a pre-meeting intimation. Actual results and any associated sentiment will be revealed after the May 18 meeting.